AVITA Medical (AVHHL) Cash from Investing Activities (2019 - 2025)
AVITA Medical's (AVHHL) quarterly Cash from Investing Activities came in at $11000.0 in Q4 2025, down 99.55% on a YoY basis from $2.5 million in Q4 2024, and up 100.21% quarter-over-quarter from -$5.3 million in Q3 2025.
Analysis
AVITA Medical (AVHHL) Cash from Investing Activities (2019 - 2025) Analysis & Trends
AVITA Medical (AVHHL) has reported Cash from Investing Activities for 7 consecutive years, with $11000.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Cash from Investing Activities fell 99.55% year-over-year to $11000.0; the trailing twelve-month figure through Dec 2025 stood at $12.5 million (down 66.67% YoY), and the FY2025 full-year result was $12.5 million, down 66.67% from the prior year.
- Cash from Investing Activities rose to $11000.0 in Q4 2025 per AVHHL's latest filing, from -$5.3 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $56.6 million in Q4 2022 and bottomed at -$57.3 million in Q4 2023.
- Historically, Cash from Investing Activities has averaged $2.0 million across 5 years, with a median of $7.0 million in 2025.
- The sharpest annual moves came in 2021 and 2023: Cash from Investing Activities tumbled 16853.38% in 2021, then surged 183.12% in 2023.
- Over 5 years, Cash from Investing Activities stood at -$50.2 million in 2021, then jumped by 212.81% to $56.6 million in 2022, then slumped by 201.23% to -$57.3 million in 2023, then soared by 104.31% to $2.5 million in 2024, then sank by 99.55% to $11000.0 in 2025.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered $11000.0, -$5.3 million, and $7.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.69 Bn | 179.09 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 124.81 Bn | 119.59 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 118.82 Bn | 110.00 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 104.59 Bn | 101.11 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 67.22 Bn | 66.69 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.87 Bn | 45.62 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.98 Bn | 32.52 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.23 Bn | 30.28 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.21 Bn | 20.72 Bn | 684.20 Mn | -108.50 Mn |
| 10 | AVITA Medical | 61.85 Mn | 50.72 Mn | 17.77 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | -5.34 Mn |
| Jun 30, 2025 | 7.02 Mn |
| Mar 31, 2025 | 10.77 Mn |
| Dec 31, 2024 | 2.47 Mn |
| Sep 30, 2024 | 7.39 Mn |
| Jun 30, 2024 | 12.43 Mn |
| Mar 31, 2024 | 15.07 Mn |
| Dec 31, 2023 | -57.30 Mn |
| Sep 30, 2023 | 21.76 Mn |
| Jun 30, 2023 | 18.36 Mn |
| Mar 31, 2023 | 18.79 Mn |
| Dec 31, 2022 | 56.61 Mn |
| Mar 31, 2022 | -22.60 Mn |
| Sep 30, 2021 | -50.18 Mn |
| Jun 30, 2021 | -526,000.00 |
| Mar 31, 2021 | -362,000.00 |
| Dec 31, 2020 | -339,000.00 |
| Sep 30, 2020 | -296,000.00 |
| Jun 30, 2020 | -200,000.00 |